Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16613223 | 0.88 | KMT2A (0.56) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL7268 | 0.86 | KMT2A (0.68) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL537642 | 0.85 | CHRNA7 (0.60) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL18542682 | 0.85 | KMT2A (0.54) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL28625965 | 0.85 | KMT2A (0.67) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL16797270 | 0.83 | KMT2A (0.52) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL21350911 | 0.82 | KMT2A (0.57) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL16598061 | 0.82 | KMT2A (0.57) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL952061 | 0.82 | FAAH (0.53) | KMT2AGAAMAPTTP53POLB | |
| SCHEMBL9203093 | 0.80 | CHRNA7 (0.72) | KMT2AMAPTCA9ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102659683-B | Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound | IHARA CHEMICAL IND CO | 2014-11-12 | — | — | CN | disclosed |
| CN-1938278-B | Process for producing 5-hydroxy-4-thiomethylpyrazole compound | IHARA CHEMICAL IND CO | 2012-12-12 | — | — | CN | disclosed |
| CN-102659683-A | Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound | IHARA CHEMICAL IND CO | 2012-09-12 | — | — | CN | disclosed |
| CN-101384556-B | Process for producing 5-alkoxy-4-hydroxymethylpyrazole compound | IHARA CHEMICAL IND CO | 2012-06-20 | — | — | CN | disclosed |
| EP-1990336-B1 | PROCESS FOR PRODUCTION OF 5-ALKOXY-4-HYDROXYMETHYLPYRAZOLE COMPOUND | IHARA CHEMICAL IND CO (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-7812175-B2 | Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| CN-101384556-A | Process for producing 5-alkoxy-4-hydroxymethylpyrazole compound | IHARA CHEMICAL IND CO (JP) | 2009-03-11 | — | — | CN | disclosed |
| US-7488831-B2 | Process for producing 5-hydroxy-4-thiomethylpyrazole compound | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-02-10 | — | — | US | disclosed |
| US-20090036688-A1 | Process for Production of 5-Alkoxy-4-Hydroxymethylpyrazole Compound | IHARA CHEMICAL INDUSTRY CO., LTD (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-1990336-A1 | PROCESS FOR PRODUCTION OF 5-ALKOXY-4-HYDROXYMETHYLPYRAZOLE COMPOUND | Ihara Chemical Industry Co., Ltd. (JP) | 2008-11-12 | — | — | EP | disclosed |
| US-20070185334-A1 | Process for producing 5-hydroxy-4-thiomethylpyrazole compound | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1767528-A1 | PROCESS FOR PRODUCING 5-HYDROXY-4-THIOMETHYLPYRAZOLE COMPOUND | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2007-03-28 | — | — | EP | disclosed |
| CN-1938278-A | Process for producing 5-hydroxy-4-thiomethylpyrazole compound | IHARA CHEMICAL IND CO (JP) | 2007-03-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036688-A1 | Process for Production of 5-Alkoxy-4-Hydroxymethylpyrazole Compound | CYP4F3, ADH5, CYP3A4 | KMT2A 841/4885GAA 2430/4885MAPT 4185/4885 |
| US-20070185334-A1 | Process for producing 5-hydroxy-4-thiomethylpyrazole compound | CYP3A5, CYP4F11, GTF3C5 | KMT2A 1779/4885GAA 595/4885MAPT 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.